AstraZeneca
forward looking statements | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
July 2021
Slide
2 of 42
Similar slides by AstraZeneca
See diffirences between slides (animation)
Results
November 2024
forward looking statements in order among other things to the safe harbour provisions of the us private securities litigation reform act of hereafter the group provides the following cautionary statement this document contains certain forward looking statements with respect to the operations performance and financial condition of the group including among other things statements about expected revenues margins earnings per share or other financial or other measures although the group believes its expectations are based on reasonable assumptions any forward looking statements by their very nature involve risks and uncertainties and may be influenced by factors that could cause actual outcomes and results to be materially different from those predicted the forward looking statements reflect knowledge and information available at the date of preparation of this document and the group undertakes no obligation to update these forward looking statements the group identifies the forward looking statements by using the words anticipates believes expects intends and similar expressions in such statements important factors that could cause actual results to differ materially from those contained in forward looking statements certain of which are beyond the group control include among other things the risk of failure or delay in delivery of pipeline or launch of new medicines the risk of failure to meet regulatory or ethical requirements for medicine development or approval the risk of failures or delays in the quality or execution of the group commercial strategies the risk of pricing access and competitive pressures the risk of failure to maintain supply of compliant quality medicines the risk of illegal trade in the group medicines the impact of reliance on third party goods and services the risk of failure in information technology or the risk of failure of critical processes the risk of failure to collect and manage data in line with legal and regulatory requirements and strategic objectives the risk of failure to attract develop engage and retain a diverse talented and capable the risk of failure to meet regulatory or ethical expectations on environmental impact including climate change the risk of the safety and efficacy of marketed medicines being questioned the risk of adverse outcome of litigation and or governmental investigations intellectual property related risks to the group products the risk of failure to achieve strategic plans or meet targets or expectations the risk of failure in financial control or the occurrence of fraud the risk of unexpected deterioration in the group financial position the impact that global and or geopolitical events may have or continue to have on these risks on the group ability to continue to mitigate these risks and on the group operations financial results or financial condition nothing in this document or any related presentation should be construed as a profit forecast | AstraZeneca
Investor Event
September 2024
forward looking statements | AstraZeneca
Results
February 2024
forward looking statements | AstraZeneca
Investor Conference
January 2024
forward looking statements | AstraZeneca
Related slides by other companies
Idacorp
Results
November 2023
forward looking statements looking | Idacorp
NVIDIA
Investor Conference
September 2021
| NVIDIA
Oculis
Investor Presentation
April 2024
safe harbor statements | Oculis
Snap Inc
Results
April 2023
forward looking statements non financial measures | Snap Inc
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights